Commentary
Commentary
/ VOLUME 3, ISSUE 1, APRIL 2021
Kenan Midilli
Coronaviruses are known to evolve slower than the other RNA viruses; however, SARS-CoV-2 underwent a major shift through D614G change in February 2020, even before the declaration of a pandemic by WHO and D614G variant became rapidly dominant throughout the world. The spike protein of this variant with D614G change have a higher affinity to […] Read More
Commentary
/ VOLUME 2, ISSUE 1, APRIL 2020
Jordi Rello and Ricardo Serrano
In the treatment of COVID-19, attention is focused on expensive, high technology equipment such as sophisticated ventilators or extracorporeal membrane oxygenation (ECMO), which requires highly trained health care workers and aggressive pharmacological measures with weak evidence of efficacy. Read More
Commentary
/ VOLUME 2, ISSUE 1, APRIL 2020
Mahir Kapmaz
This paper is dedicated to the memory of legendary clinician, Professor Cemil Taşçıoğlu who succumbed to COVID-19. I am an Infectious Diseases and Clinical Microbiology physician. We were at the frontline of the battle of COVID-19 soon after the first case in Turkey, that was officially declared on 11 March 2020. Rick Penciner was a […] Read More